XYA-2:一种来自海洋的化合物,向胰腺癌中的亡和多个信号通路
Xiaoqing Guan1,2, Yun Li1, Xiaodan Guan1
1Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang, China.
PeerJ
|January 22, 2024
概括
XYA-2是一种来自深海真菌的化合物,有效地抑制胰腺癌细胞的生长,迁移和入侵. 它还诱导细胞循环停止和细胞亡,显示作为一种新的胰腺癌治疗的希望.
科学领域:
- 海洋天然产品化学 海洋天然产品化学
- 癌症生物学 癌症生物学
- 药物发现 药物发现
背景情况:
- 胰腺癌是一种侵袭性疾病,患者的预后不佳,治疗选择有限.
- XYA-2是一种来自深海真菌的化阿扎菲隆,研究了其抗癌作用.
- 这项研究重点关注XYA-2对胰腺癌细胞进展的影响.
研究的目的:
- 评估XYA-2在抑制胰腺癌细胞增殖,克隆性潜力,细胞周期进展,亡,迁移和入侵方面的疗效.
- 阐明XYA-2在胰腺癌细胞中的作用背后的分子机制.
- 评估XYA-2作为胰腺癌治疗剂的潜力.
主要方法:
- 用CCK-8试验评估细胞增殖.
- 分别使用克隆形成,流细胞计,伤口愈合和跨井检测来评估克隆性潜力,细胞循环,细胞亡,迁移和入侵.
- 用RNA测序和生物信息学分析来识别分子标,通过qRT-PCR进行验证.
主要成果:
- XYA-2证明了胰腺癌细胞增殖的剂量依赖抑制.
- 该化合物诱导癌细胞的细胞循环停止和细胞亡.
- XYA-2显著抑制了癌细胞的迁移和入侵,并调节了癌症相关途径中的基因.
结论:
- XYA-2 具有显著的抗胰腺癌活性.
- 该化合物的抑制扩散,迁移和入侵的能力使其成为潜在的治疗候选者.
- 对XYA-2的进一步研究可能会导致胰腺癌的新治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.9K
相关概念视频
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
